These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26078037)

  • 1. Structure-based design of diverse inhibitors of Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase: combined molecular docking, dynamic simulation, and biological activity.
    Soni V; Suryadevara P; Sriram D; ; Kumar S; Nandicoori VK; Yogeeswari P
    J Mol Model; 2015 Jul; 21(7):174. PubMed ID: 26078037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
    Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
    Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition studies on Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase (GlmU).
    Tran AT; Wen D; West NP; Baker EN; Britton WJ; Payne RJ
    Org Biomol Chem; 2013 Dec; 11(46):8113-26. PubMed ID: 24158720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PknB-mediated phosphorylation of a novel substrate, N-acetylglucosamine-1-phosphate uridyltransferase, modulates its acetyltransferase activity.
    Parikh A; Verma SK; Khan S; Prakash B; Nandicoori VK
    J Mol Biol; 2009 Feb; 386(2):451-64. PubMed ID: 19121323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of substrate binding and catalysis in the potential antibacterial target N-acetylglucosamine-1-phosphate uridyltransferase (GlmU).
    Mochalkin I; Lightle S; Zhu Y; Ohren JF; Spessard C; Chirgadze NY; Banotai C; Melnick M; McDowell L
    Protein Sci; 2007 Dec; 16(12):2657-66. PubMed ID: 18029420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structures of Streptococcus pneumoniae N-acetylglucosamine-1-phosphate uridyltransferase, GlmU, in apo form at 2.33 A resolution and in complex with UDP-N-acetylglucosamine and Mg(2+) at 1.96 A resolution.
    Kostrewa D; D'Arcy A; Takacs B; Kamber M
    J Mol Biol; 2001 Jan; 305(2):279-89. PubMed ID: 11124906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression, essentiality, and a microtiter plate assay for mycobacterial GlmU, the bifunctional glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase.
    Zhang W; Jones VC; Scherman MS; Mahapatra S; Crick D; Bhamidi S; Xin Y; McNeil MR; Ma Y
    Int J Biochem Cell Biol; 2008; 40(11):2560-71. PubMed ID: 18573680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations.
    Saxena S; Abdullah M; Sriram D; Guruprasad L
    J Biomol Struct Dyn; 2018 Sep; 36(12):3184-3198. PubMed ID: 28948866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computationally Guided Identification of Novel Mycobacterium tuberculosis GlmU Inhibitory Leads, Their Optimization, and in Vitro Validation.
    Mehra R; Rani C; Mahajan P; Vishwakarma RA; Khan IA; Nargotra A
    ACS Comb Sci; 2016 Feb; 18(2):100-16. PubMed ID: 26812086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Mtb GlmU Uridyltransferase Domain Inhibitors by Ligand-Based and Structure-Based Drug Design Approaches.
    Singh M; Kempanna P; Bharatham K
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel lead compound optimization and synthesized based on the target structure of Xanthomonas oryzae pv. oryzae GlmU.
    Qi X; Deng W; Gao M; Mao B; Xu S; Chen C; Zhang Q
    Pestic Biochem Physiol; 2015 Jul; 122():22-8. PubMed ID: 26071803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and function of GlmU from Mycobacterium tuberculosis.
    Zhang Z; Bulloch EM; Bunker RD; Baker EN; Squire CJ
    Acta Crystallogr D Biol Crystallogr; 2009 Mar; 65(Pt 3):275-83. PubMed ID: 19237750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An aminoquinazoline inhibitor of the essential bacterial cell wall synthetic enzyme GlmU has a unique non-protein-kinase-like binding mode.
    Larsen NA; Nash TJ; Morningstar M; Shapiro AB; Joubran C; Blackett CJ; Patten AD; Boriack-Sjodin PA; Doig P
    Biochem J; 2012 Sep; 446(3):405-13. PubMed ID: 22721802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of novel small molecule inhibitors of the acetyltransferase activity of Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU).
    Sharma R; Rani C; Mehra R; Nargotra A; Chib R; Rajput VS; Kumar S; Singh S; Sharma PR; Khan IA
    Appl Microbiol Biotechnol; 2016 Apr; 100(7):3071-85. PubMed ID: 26563552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic properties of Mycobacterium tuberculosis bifunctional GlmU.
    Zhou Y; Xin Y; Sha S; Ma Y
    Arch Microbiol; 2011 Oct; 193(10):751-7. PubMed ID: 21594607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
    Kumar R; Garg P; Bharatam PV
    J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Synthesis of Various 5'-Deoxy-5'-(4-Substituted-1,2,3-Triazol-1-yl)-Uridine Analogues as Inhibitors of
    Hervin V; Arora R; Rani J; Ramchandran S; Bajpai U; Agrofoglio LA; Roy V
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33114668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of a small-molecule inhibitor complexed with GlmU from Haemophilus influenzae reveals an allosteric binding site.
    Mochalkin I; Lightle S; Narasimhan L; Bornemeier D; Melnick M; Vanderroest S; McDowell L
    Protein Sci; 2008 Mar; 17(3):577-82. PubMed ID: 18218712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of UDP-N-acetylglucosamine-enolpyruvate reductase (MurB) from Mycobacterium tuberculosis.
    Eniyan K; Dharavath S; Vijayan R; Bajpai U; Gourinath S
    Biochim Biophys Acta Proteins Proteom; 2018 Mar; 1866(3):397-406. PubMed ID: 29203374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 1: Hit to lead evaluation of a novel arylsulfonamide series.
    Green OM; McKenzie AR; Shapiro AB; Otterbein L; Ni H; Patten A; Stokes S; Albert R; Kawatkar S; Breed J
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1510-9. PubMed ID: 22297115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.